Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$30.27 - $43.79 $3,027 - $4,379
-100 Reduced 1.28%
7,700 $248,000
Q4 2023

Feb 14, 2024

BUY
$31.31 - $44.19 $219,170 - $309,330
7,000 Added 875.0%
7,800 $328,000
Q3 2023

Nov 14, 2023

BUY
$18.55 - $39.96 $14,840 - $31,968
800 New
800 $30,000
Q3 2021

Nov 15, 2021

SELL
$7.01 - $11.37 $701 - $1,137
-100 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$9.4 - $16.85 $940 - $1,685
100 New
100 $1,000

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.